Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
09/2009
09/08/2009US7585871 Phenanthridine carbonyl phenols
09/08/2009CA2213466C Inhibitors of microsomal triglyceride transfer protein and method
09/03/2009WO2009108332A1 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
09/03/2009WO2009107389A1 Tricyclic compound
09/03/2009CA2716128A1 Inhibitors of 11.beta.-hydroxysteroid dehydrogenase type 1
09/02/2009EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase
09/02/2009EP2094649A2 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines
09/02/2009EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation
09/02/2009CN101522635A Method for producing piperidin-4-one-derivative
09/02/2009CN101522634A Process for production of azabicycloalkanol derivative
09/01/2009US7582763 Enantioselective process
09/01/2009US7582650 9-(8-Aza-bicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-4-carboxylic acid amide; veterinary formulation for treating mild to severe pain
08/2009
08/27/2009US20090216022 Cyclopamine analogs
08/27/2009US20090215815 Neurotrophin antagonist compositions
08/27/2009US20090215814 Method of inhibiting neurotrophin-receptor binding
08/27/2009US20090215807 Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated Diseases
08/27/2009US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid
08/27/2009US20090214460 Composition Comprising a Monomer Compound Exhibiting an Optical Property, Method Making Use of Said Composition, a Monomer Compound and a Polymer Containing Said Monomer Compound and the Use Thereof
08/26/2009CN101513426A Cinnamylate lipoid substance and application thereof in the preparation of leukotriene A4 hydrolytic enzyme functional regulating medicine
08/20/2009WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/20/2009CA2714331A1 Selective opioid compounds
08/20/2009CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/19/2009EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
08/19/2009EP2089390A1 Heptarylene and octarylene tetracarboxylic acid diimides, and production thereof
08/19/2009CN100528844C Huperzine A derivative, preparation method and application thereof
08/19/2009CN100528168C 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
08/18/2009US7576094 5,7,8-Trimethyl-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-6-ol; also analogous thiochromenes; antiapoptosis; anticarcinogenic agents; antihypoxic agents; anoxia; antiinflamatory agents; central nervous system disorders; autoimmune diseases; neurodegenerative disorders
08/18/2009US7576072 Heterocyclic inhibitors of MEK and methods of use thereof
08/18/2009CA2495721C Non-nucleoside reverse transcriptase inhibitors
08/18/2009CA2479216C Dipyridodiazepinones as reverse transcriptase inhibitors
08/18/2009CA2429133C Novel imidazole derivatives, production method thereof and use thereof
08/18/2009CA2362760C Camptothecin derivatives having antitumor activity
08/18/2009CA2347853C Process for racemization of [2-(2-thienyl)ethylamino] (2-halogenophenyl)acetamides
08/18/2009CA2276764C Acridine derivatives as opioid analgesics
08/13/2009US20090203728 Naphthalamide derivatives having antiproliferative activity
08/13/2009US20090203726 Substituted tetrahydroquinolines as antibacterial agents
08/13/2009US20090203724 Solid and crystalline dutasteride and processes for preparation thereof
08/12/2009EP2086534A1 Compounds, compositions and methods for controlling invertebrate pests
08/12/2009EP1385514B9 Spiroindene and spiroindane compounds
08/12/2009CN101506172A Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2 -methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
08/11/2009US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid
08/06/2009WO2009095376A1 Derivatives of 1,8-naphthalimide as scintillation agents, especially for the discrimination between fast neutrons and gamma rays
08/06/2009US20090197908 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
08/06/2009US20090197907 Novel crystalline form of rupatadine free base
08/06/2009US20090197905 Quaternary opioid carboxamides
08/06/2009US20090197198 Photosensitive molecular compound and photoresist composition including the same
08/05/2009EP1805144A4 Heterocyclical chromophore architectures
08/05/2009EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/05/2009EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor
08/05/2009CN101500565A Modulators of muscarinic receptors
08/05/2009CN100522971C Method for synthesizing oxazole pyridone compound
07/2009
07/30/2009WO2009093433A1 Anthrapyridone compound or salt thereof, magenta ink composition containing the anthrapyridone compound, and colored body
07/30/2009CA2713140A1 Anthrapyridone compound or a salt thereof, magenta ink composition containing the anthrapyridone compound and colored product
07/29/2009CN101492420A Synthesis of whorl(1-tetrahydronaphthalene-4,4'-piperidine) derivative
07/29/2009CN100519534C Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
07/28/2009US7566731 2-(Chloro),4-(ethoxycarbonyl-isoprop-2,2-ylene-isoprop-2,2-ylene-oxycarbonyl-methyl),5-(methyl-thiazole; bactericides; herbicides; insecticides; fungicides; nematocides; algicides; molluscicides; construction materials; wood; clay; alkali resistance
07/23/2009WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
07/23/2009WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
07/23/2009US20090186916 Aminoindane derivative or salt thereof
07/22/2009EP2080760A1 Fused quinoline derivative and use thereof
07/22/2009EP2080755A1 Process for production of azabicycloalkanol derivative
07/22/2009EP1503988B1 Fredericamycin derivatives
07/22/2009CN101490008A Fused heterocyclic compound and organic light emitting device
07/21/2009US7563801 With lactose, microcrystalline cellulose, croscarmellose sodium, pregelatinized starch, and magnesium stearate; storage stability; capsules; anticancer agents
07/16/2009WO2008144394A3 Fused-ring heterocycle opioids
07/16/2009US20090182006 Treating a respiratory disorder by administering a hydrate of Gemifloxacinwith a carrier or excipient; chemical resistance; humidity; storage stability; thermodynamics; materials handling; sksin disorders; soft tissue-targeted therapy; sexual disorders; bovine mastitis; veterinary medicine
07/16/2009US20090182002 Tyrosine kinase inhibitors
07/16/2009US20090182000 Steroidal compounds as steroid sulphatase inhibitors
07/16/2009US20090181999 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders
07/16/2009US20090181971 Inhibitors of Histone Deacetylase
07/15/2009EP1744758A4 Radiopharmaceutical and methods of synthesis and use thereof
07/15/2009EP1711469B1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
07/14/2009US7560556 Assay methods using chemiluminescent detection of peroxidase
07/14/2009CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
07/09/2009WO2009086416A1 Therapeutic cancer treatments
07/09/2009US20090176705 Modular platform for targeted therapeutic delivery
07/09/2009CA2710377A1 Therapeutic cancer treatments
07/08/2009CN101479247A 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509811C Azaindoles
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100508975C Use of pyrazolopyridine compound
07/07/2009USRE40838 modulators of opioid receptors; irritable bowel syndrome, drug addiction, including alcohol addiction, depression, anxiety, schizophrenia, eating disorders
07/07/2009US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
07/07/2009US7557119 analgesics, antidiarrheal agents, anticonvulsants, antitussives, anti-addiction; 8-Substituted-2,6-methano-3-benzazocines
07/02/2009WO2009080198A1 Fused cynopryridines and the use thereof
07/02/2009US20090170892 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors
07/02/2009US20090170889 Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders
07/02/2009US20090169508 Opioid and opioid-like compounds and uses thereof
07/01/2009EP2074099A1 Quinolinone derivatives
06/2009
06/30/2009US7553965 Central nervous system disorders; compounds are 3-sulfonamidoalkyl 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylenes
06/30/2009US7553959 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
06/30/2009US7553842 Topically active FK520 and FK506 analogs; calcineurin inhibitorse useful in the treatment of immunoregulatory and respiratory disorders; lung or heart transplantation; antiinflammatory agents; bronchitis; asthma; immunosuppressants; autoimmune diseases eosinophil-related diseases
06/30/2009US7553841 Amino cyclobutylamide modulators of chemokine receptor activity
06/30/2009US7553828 Treating antibiotic resistant infections such as Escherichia coli, Staphylococcus aureus, E. faecalis
06/30/2009US7553336 Brightening direct dyes for keratin fibers and colorants containing these compounds
06/25/2009WO2009078988A1 Sinomenine derivatives and processes for their synthesis
06/25/2009WO2009078987A1 Process and compounds for the production of (+) opiates
06/25/2009US20090163534 Indolizine Derivatives
06/25/2009US20090163485 Heteroaryl derivatives as orexin receptor antagonists
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 110